Singrow
Summary
Singrow is pioneering climate-resilient strawberry cultivation through biotechnology and vertical farming innovations. Their proprietary white (Crystal) and hybrid Ruby red strawberries are bred to withstand heat and humidity, enabling efficient local production in tropical and subtropical regions where commercial strawberry cultivation is typically unfeasible. By growing locally, Singrow significantly reduces both the carbon footprint and costs associated with imported strawberries, which are often harvested underripe and lack full sweetness. With a brix score of at least 12 – double that of standard commercial strawberries – Singrow’s varieties rival premium Japanese and Korean imports but at a fraction of the price. Beyond breeding, Singrow has developed a patent-protected hydroponic racking system that optimizes airflow, mitigates humidity challenges, and facilitates robotic harvesting. Targeting China and Southeast Asia, which account for over half of the $15 billion global strawberry market, Singrow employs a partnership and licensing model with large state-owned enterprises to ensure scalability and IP protection.
Investors
Team
Bao Shengjie Co-founder and CEO
Dr. Bao Shengjie is the founder and Chief Executive Officer of Singrow, a Singapore-based agri-genomics firm renowned for developing the world’s first climate-resilient strawberries. He earned his Ph.D. in molecular biology from the National University of Singapore (NUS) and serves as an Adjunct Lecturer in the Department of Biological Sciences at NUS. Dr. Bao’s research focuses on urban agriculture, molecular breeding, plant physiology, and flowering time control in horticultural crops.
Yu Hao Co-founder
Professor Yu Hao is the Director of the Temasek Life Sciences Laboratory (TLL) in Singapore, where he leads research in plant molecular genetics and crop biotechnology to address challenges in human well-being. He also serves as Provost’s Chair Professor and Head of the Department of Biological Sciences at the National University of Singapore (NUS). Professor Yu’s work focuses on developmental biology, neurodegenerative diseases, and genetics and genomics. He was appointed Executive Director of TLL in December 2014.
